Peter C Gøtzsche, MD exposes the pharmaceutical industries and their charade of fraudulent behaviour, both in research and marketing where the morally repugnant disregard for human lives is the norm. Peter C. Gøtzsche, MD is a Danish medical researcher, and leader of the Nordic Cochrane Center at Rigshospitalet in Copenhagen, Denmark. He has written numerous reviews within the Cochrane collaboration.
This editorial written and published in the British Medical Journal does a good job of explaining why criminal settlements against pharmaceutical companies do NOT stop criminal behavior in the pharmaceutical industry. 20% of all corporate crime is now committed by pharmaceutical companies, and those are just the cases that are litigated and settled. The problem with corruption in scientific studies that are used to approve drugs do not even come up in litigation. As Sidney M Wolfe points out in this article published last month in the British Medical Journal, the fines and penalties levied against corporations are just to0 small, and they are simply considered as part of the "cost of doing business" which lead to higher drug prices passed on to the consumers.
by Dr. Mercola
Over the course of the past two decades, U.S. spending on prescription drugs increased from $40 billion to more than $230 billion.
Illegal drug company activities are one factor contributing to this inflated spending.
One 2010 study looked at trends in federal and state criminal and civil actions against drug companies in […]
